SOURCE: Fresh Start Private Management Inc.

Fresh Start Private Management Inc.

April 19, 2011 16:00 ET

Fresh Start Private Processes Over $3.8 Million in Insurance Claims in First Quarter

Company Capitalizing on Marketing Efforts Through Its Agreement With Clear Channel

LOS ANGELES, CA--(Marketwire - Apr 19, 2011) - Fresh Start Private (OTCBB: CEYY), a leader in the alcohol treatment and rehabilitation industry, announced today that it has processed over $3.8 Million dollars in insurance claims at its Orange Country clinic from January 1 to March 30, 2011.

The Company noted that its positive momentum in the marketplace continues as its moves into the second quarter of 2011 and that its strategy of marketing is leading with its emergence as a strong player in the alcohol treatment industry.

Fresh Start Private's (FSP) goal is to meet its growth targets through partnership opportunities by promoting its product and services to existing medical clinics and treatment centers that will be charged a Licensing fee and a percentage of sales.

At the same time, FSP has already opened one corporately owned clinic and that this first facility is operational and able to treat up to 15 patients a day with potential revenue of $120 Million per year per clinic. The intent is for FSP to open more clinics in areas that show demand and excellent ROI.

Fresh Start Private (FSP) is the only alcohol treatment program to offer a single-administration, licensed long-acting, Naltrexone implant procedure. Naltrexone has been approved for use by the FDA within the United States for the treatment of alcohol.

The company notes that the numbers contained in this release are unaudited, and are made in good faith and based on all the financial information available to the company today. Further, past financial business, operations and stock performance are not necessarily indicative of the company's future performance.

About Fresh Start Private

Fresh Start Private is an alcohol addiction, alcohol withdrawal, alcohol abuse treatment and alcohol detox rehabilitation company on the leading edge of the alcohol addiction treatment. The Company has licensed a highly effective treatment delivers target therapeutic levels of Naltrexone that significantly reduce patients' cravings for alcohol.

Please visit

Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "optimizing," "potential," "anticipate," "goal," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Fresh Start filings with the Securities and Exchange Commission.

Contact Information

  • Contact:
    Investor Relations
    Bill Clayton
    Toll Free (877) 521-CEYY (2399)
    Email Contact